M
Masaki Yamada
Researcher at Astellas Pharma
Publications - 1
Citations - 154
Masaki Yamada is an academic researcher from Astellas Pharma. The author has contributed to research in topics: Kinase & Myeloid leukemia. The author has an hindex of 1, co-authored 1 publications receiving 103 citations.
Papers
More filters
Journal ArticleDOI
Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
Masamichi Mori,Naoki Kaneko,Yoko Ueno,Masaki Yamada,Ruriko Tanaka,Rika Saito,Itsuro Shimada,Kenichi Mori,Sadao Kuromitsu +8 more
TL;DR: Results indicate that gilteritinib may be an important next-generationFLT3 inhibitor for use in the treatment of FLT3 mutation-positive AML.